1, Yantai Zhenghai Magnetic Material Co.Ltd(300224) : it is estimated that the net profit in 2021 will increase by 90% - 120% year-on-year
Yantai Zhenghai Magnetic Material Co.Ltd(300224) (300224) announced that the company's pre profit in 2021 was 253 million yuan - 293 million yuan, with a year-on-year increase of 90% - 120%. During the reporting period, the sales revenue and net profit of high-performance Nd-Fe-B permanent magnet materials increased significantly compared with the same period last year; The business income of motor drive system of new energy vehicles increased significantly, and the loss decreased significantly. Xiaocai note: Q3 net profit is 69 million yuan. Based on this calculation, Q4 net profit is expected to be 69 million yuan - 109 million yuan, with a month on month change of 0% - 57%.
2, Power Construction Corporation Of China Ltd(Powerchina Ltd)(601669) : it is proposed to replace the assets of the real estate sector with the assets related to the high-quality power grid auxiliary industry of the controlling shareholder
Power Construction Corporation Of China Ltd(Powerchina Ltd)(601669) (601669) announced that the company plans to replace the assets with the power construction group, and the company will replace the real estate assets held by the company with the high-quality power grid auxiliary assets held by the power construction group. The transaction is planned to be conducted by means of non-public agreement transfer, with a total of 24.719 billion yuan of assets disposed and 24.653 billion yuan of assets disposed. The difference between disposed assets and disposed assets is 65.3426 million yuan, which is paid to the company by power construction group in cash.
3, Sansure Biotech Inc(688289) : New Coronavirus mutant nucleic acid test kit was obtained from the Ministry of health of France for .
Sansure Biotech Inc(688289) (688289) announced that the company's product human papillomavirus nucleic acid detection kit (PCR fluorescent probe method) recently received the medical device registration certificate issued by the State Drug Administration. The New Coronavirus (SARS-CoV-2) L452R/E484K/K417N mutant nucleic acid detection kit (fluorescence PCR method) was recently approved by the Ministry of health of France. The kit can be used for preliminary judgement of the variant of the PCR in the guidelines of the Ministry of health of France. The results can be used to determine whether there are mutations in L452R, E484K and K417N genes in the infected patients. Better assist in rapid epidemic detection and prevention and control.
4, Changzheng Engineering Co.Ltd(603698) : it is proposed to sign a clean and efficient comprehensive utilization project contract of RMB 1.466 billion with Cangzhou gas
Changzheng Engineering Co.Ltd(603698) (603698) announced that it plans to sign the EPC contract for clean and efficient comprehensive utilization of coal (air separation, gasification, purification unit and its supporting works) with aerospace hydrogen Cangzhou Gas Co., Ltd., with a total contract amount of 1.466 billion yuan.
5, Andon Health Co.Ltd(002432) : Omicron active virus sample detected by self-test OTC Kit
Andon Health Co.Ltd(002432) (002432) announced that the subsidiary received the performance test report of the ihalath covid-19 antigen home self-test OTC kit for Omicron mutant virus. The report showed that 100% of the Omicron active virus samples with a maximum CT value of 21.59 (n = 5) were detected in the experiment.
6, Shifeng Cultural Development Co.Ltd(002862) : it is proposed to increase capital to obtain no less than 20% equity
Shifeng Cultural Development Co.Ltd(002862) (002862) announced that it plans to obtain no less than 20% equity of Chongqing Huanli New Energy Technology Co., Ltd. through capital increase, and the specific amount and proportion of capital increase have not been finalized.
7, Great Wall Motor Company Limited(601633) : the annual sales volume in 2021 increased by 15% year-on-year, and the sales volume of new energy vehicles was 137000
Great Wall Motor Company Limited(601633) (601633) announced that the total sales volume in December was 162369, with a year-on-year increase of 8.17%; The annual sales volume was 1.28 million, a year-on-year increase of 15.24%. 22354 new energy vehicles were sold in December, and 136953 were sold from January to December.
8, Pangang Group Vanadium Titanium & Resources Co.Ltd(000629) : the net profit in 2021 is expected to increase by 236% - 262%
According to the announcement of Pangang Group Vanadium Titanium & Resources Co.Ltd(000629) (000629), the net profit in 2021 is expected to be 1.28 billion yuan - 1.38 billion yuan, an increase of 236.03% - 262.29% over the same period of last year (after adjustment). During the reporting period, the company made every effort to connect production and sales, and the price and sales volume of vanadium and titanium products increased significantly year-on-year. Xiaocai note: the net profit of Q3 is 275 million yuan. Based on this calculation, the net profit of Q4 is expected to be 498 million yuan - 598 million yuan, an increase of 81% - 117% month on month.
9, Jiangsu Baichuan High-Tech New Materials Co.Ltd(002455) : the net profit in 2021 increased by 201% - 276% year-on-year
According to the announcement of Jiangsu Baichuan High-Tech New Materials Co.Ltd(002455) (002455), it is expected to realize a net profit of RMB 200 million-250 million in 2021, with a year-on-year increase of 200.95% - 276.19%. During the reporting period, the market demand of the company's main products was strong, and the sales price and sales volume increased significantly. Xiaocai note: the net profit of Q3 is 42 million yuan. Based on this calculation, the net profit of Q4 is expected to be 76 million yuan - 126 million yuan, an increase of 78% - 193% month on month.
10, Beijing Scitop Bio-Tech Co.Ltd(300858) : some anti Helicobacter pylori effects have been scientifically tested and clinically verified, and relevant patents are being applied for
Beijing Scitop Bio-Tech Co.Ltd(300858) (300858) issued a change announcement. The company found that the concept of Helicobacter pylori had been reported by the public media recently, which made the A-share secondary market pay more attention to the concept of "Helicobacter pylori". The company is a high-tech enterprise mainly engaged in the R & D, production and sales of compound food additives, edible probiotic products and animal and plant probiotics. In recent years, the company has conducted scientific experiments and clinical verification on the anti Helicobacter pylori efficacy of some core strains, and is applying for relevant patents.
(Jufeng Finance)
